Goodall et al., 1982 - Google Patents
Preparation of factor IX deficient human plasma by immunoaffinity chromatography using a monoclonal antibodyGoodall et al., 1982
View HTML- Document ID
- 6822545409470671498
- Author
- Goodall A
- Kemble G
- O'Brien D
- Rawlings E
- Rotblat F
- Russell G
- Janossy G
- Tuddenham E
- Publication year
External Links
Snippet
A murine hybridoma clone is described that grows continuously in culture and produces a monoclonal antibody we have called Royal Free Monoclonal Antibody to factor IX No. 1 (RFF-IX/1). This has high affinity for a coagulation site on factor IX. RFF-IX/1 immobilised on …
- 210000002381 Plasma 0 title abstract description 51
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3315405B2 (en) | Monoclonal antibodies against receptor-induced binding sites | |
KR100406072B1 (en) | Antithrombotic and Anti-von Willebrand Factor Monoclonal Antibodies | |
Martinez et al. | Fibrinogen Philadelphia. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism. | |
CA1341506C (en) | Factor viii coagulant polypeptides and monoclonal antibodies to them | |
Goodall et al. | Preparation of factor IX deficient human plasma by immunoaffinity chromatography using a monoclonal antibody | |
KR940002033B1 (en) | Monoclonal antibody against protein c | |
AU650312B2 (en) | Characterization of platelet aggregation disorders | |
Rotblat et al. | Monoclonal antibodies to human procoagulant factor VIII | |
EP0162078B1 (en) | Method for isolating a protein from a mixture containing said protein and a conformation specific antibody useful therein | |
Jennings et al. | Monoclonal antibodies to human platelet glycoprotein IIb beta that initiate distinct platelet responses | |
EP0678524B1 (en) | Anti-human soluble fibrin antibodies, hybridoma producing them, and immunoassaying method | |
Griffin et al. | The production and characterisation of a panel of ten murine monoclonal antibodies to human procoagulant factor VIII | |
Muller et al. | A monoclonal antibody to VIII: C produced by a mouse hybridoma | |
Katzmann et al. | Monoclonal antibodies to von Willebrand's factor: reactivity with porcine and human antigens | |
Fournier et al. | A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation | |
US5231025A (en) | Anti-platelet monoclonal antibody | |
Jallu et al. | Characterization of an antibody to the integrin β3 subunit (GP IIIa) from a patient with neonatal thrombocytopenia and an inherited deficiency of GP IIb-IIIa complexes in platelets (Glanzmann's thrombasthenia) | |
Wautier et al. | C1 and human platelets. II. Detection by immunological methods and role. | |
Ogata et al. | The relationship of the properties of antihemophilic factor (factor VIII) that support ristocetin-induced platelet agglutination (factor VIIIR: RC) and platelet retention by glass beads as demonstrated by a monoclonal antibody | |
EP0152746A2 (en) | Hybridoma cell lines and monoclonal antibodies to factor VIIIC | |
EP0437547B1 (en) | Monoclonal antibodies against receptor-induced binding sites on ligands binding to proteins of the cytoadhesin super family | |
Hoad et al. | Characterisation of monoclonal antibodies to human factor X/Xa initial observations with a quantitative ELISA procedure | |
US5101016A (en) | Factor VIII coagulant polypeptides and monoclonal antibodies to them | |
Hassouna et al. | Antibody technics and blood coagulation | |
Takami et al. | Monoclonal antibodies against porcine platelet membrane glycoproteins Ib and IIb/IIIa |